Understanding CNS Lesions in HER2+ Metastatic Breast Cancer
Sarah Sammons, MD
Systemic Management of Brain Metastases in HER2+ BC: Emerging Strategies and Treatment Approaches
Carey Anders, MD, FASCO
Optimizing Treatment Selection for HER2+ Breast Cancer Patients with Brain Metastases
Virtual Tumor Board: Maximizing the Potential of Immuno-Oncology in Early TNBC Through Personalized Care
Heather McArthur, MD
Margaret Gatti-Mays, MD, MPH
HER3-Directed ADCs in the Treatment of EGFR-Mutated Advanced or Metastatic NSCLC Progressing on TKI and Platinum-Based Chemotherapy
Pasi Antero Jänne, MD, PhD
Helena Yu, MD
Case Application: Patients With EGFRm Resistance Post TKI and Platinum Chemotherapy
Case Application: Adverse Event Management of Patients With EGFRm Resistance Treated With Novel HER3-Directed ADCs
Expert Peer Discussion: Integrating Novel HER3-Directed ADCs Upon Disease Progression Following EGFR TKI and Platinum Chemotherapy
Biologic Rationale for Targeting HER3 and Role in EGFR Resistance
Overcoming EGFR Resistance With HER3-Directed ADCs
Interprofessional Monitoring and Management of AEs With HER3-Directed ADCs
The Weight of Recurrence: Navigating Multidisciplinary Care Planning in Recurring/Metastatic Cervical Cancer
Brian Slomovitz, MD
Robert L. Coleman, MD, FACOG, FACS
Differentiating Biomarker-Driven First-Line Treatment Strategies in Metastatic Gastric/GEJ Cancers
Nataliya Uboha, MD, PhD
Bringing Treatment Into Focus: Biomarker-Driven First-Line Therapy for Metastatic Gastric/GEJ Cancers
David H. Ilson, MD, PhD
Sunnie Kim, MD
Expanding Horizons: HER2 Targeting in Metastatic Solid Tumors
Shubham Pant, MD, MBBS
Ritu Salani, MD, MBA
Significance of HER2 Expression in Solid Tumors
Loading...
We're glad to see you're enjoying MedEd On The Go… but how about a more personalized experience?
Press cancel to remain on MedEd On The Go. Press the link below or the continue button to keep going.